Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

1-25 of 58 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2 3

Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD).
Sánchez V, Baumann A, Kromm F, Yergaliyev T, Brandt A, Scholda J, Kopp F, Camarinha-Silva A, Bergheim I
Mol Med, 30(1):181, 18 Oct 2024
Cited by: 0 articles | PMID: 39425011 | PMCID: PMC11488139
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota.
Wang Y, Jia X, Cong B
Front Microbiol, 15:1396031, 24 May 2024
Cited by: 0 articles | PMID: 38855769
Add to export list Review
Advancements in metabolic-associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions.
Eeda V, Patil NY, Joshi AD, Awasthi V
Hepatol Res, 54(3):222-234, 22 Jan 2024
Cited by: 2 articles | PMID: 38149861
Add to export list Review
Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Female C57BL/6J Mice.
Sánchez V, Baumann A, Brandt A, Wodak MF, Staltner R, Bergheim I
Cell Mol Gastroenterol Hepatol, 17(5):785-800, 21 Jan 2024
Cited by: 2 articles | PMID: 38262589 | PMCID: PMC10966192
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Metformin: update on mechanisms of action on liver diseases.
Ruan G, Wu F, Shi D, Sun H, Wang F, Xu C
Front Nutr, 10:1327814, 14 Dec 2023
Cited by: 4 articles | PMID: 38192642 | PMCID: PMC10773879
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice.
Rajcic D, Kromm F, Hernández-Arriaga A, Brandt A, Baumann A, Staltner R, Camarinha-Silva A, Bergheim I
Biomolecules, 13(11):1579, 26 Oct 2023
Cited by: 0 articles | PMID: 38002262
Add to export list
The Role and Mechanism of Metformin in Inflammatory Diseases.
Lin H, Ao H, Guo G, Liu M
J Inflamm Res, 16:5545-5564, 23 Nov 2023
Cited by: 7 articles | PMID: 38026260 | PMCID: PMC10680465
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.
Zachou M, Flevari P, Nasiri-Ansari N, Varytimiadis C, Kalaitzakis E, Kassi E, Androutsakos T
Eur J Clin Pharmacol, 80(1):127-150, 08 Nov 2023
Cited by: 8 articles | PMID: 37938366 | PMCID: PMC10781828
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Effects of Probiotic Bacillus Spores on Dexamethasone-Treated Rats.
Inceu AI, Neag MA, Catinean A, Bocsan CI, Craciun CI, Melincovici CS, Muntean DM, Onofrei MM, Pop RM, Buzoianu AD
Int J Mol Sci, 24(20):15111, 12 Oct 2023
Cited by: 0 articles | PMID: 37894792 | PMCID: PMC10606902
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments.
Petagine L, Zariwala MG, Patel VB
World J Gastroenterol, 29(32):4831-4850, 01 Aug 2023
Cited by: 11 articles | PMID: 37701135 | PMCID: PMC10494768
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Fructose: a modulator of intestinal barrier function and hepatic health?
Staltner R, Burger K, Baumann A, Bergheim I
Eur J Nutr, 62(8):3113-3124, 18 Aug 2023
Cited by: 5 articles | PMID: 37596353 | PMCID: PMC10611622
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis.
Chen D, Xiong J, Chen G, Zhang Z, Liu Y, Xu J, Xu H
In Vivo, 37(5):2105-2127, 01 Sep 2023
Cited by: 2 articles | PMID: 37652508 | PMCID: PMC10500488
Add to export list Free full text in Europe PMC
TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice.
Burger K, Jung F, Baumann A, Brandt A, Staltner R, Sánchez V, Bergheim I
Redox Biol, 66:102870, 01 Sep 2023
Cited by: 3 articles | PMID: 37683301 | PMCID: PMC10493600
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.
Gkiourtzis N, Michou P, Moutafi M, Glava A, Cheirakis K, Christakopoulos A, Vouksinou E, Fotoulaki M
Eur J Pediatr, 182(11):4795-4806, 28 Aug 2023
Cited by: 2 articles | PMID: 37639015 | PMCID: PMC10640492
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice.
Yao Z, Guo J, Du B, Hong L, Zhu Y, Feng X, Hou Y, Shi A
Front Microbiol, 14:1147067, 18 Jul 2023
Cited by: 4 articles | PMID: 37538846 | PMCID: PMC10394096
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats.
Barmoudeh Z, Fouani MH, Moslemi Z, Azizi M, Doustimotlagh AH, Bardania H
Naunyn Schmiedebergs Arch Pharmacol, 397(1):395-410, 15 Jul 2023
Cited by: 0 articles | PMID: 37452836
Add to export list
The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide Study.
Okpujie V, Tobalesi O, Uwumiro F, Ugoh AC, Osiogo EO, Abesin O, Olaomi OA, Nwevo CO, Ayantoyinbo T, Ejeagha F
Cureus, 15(8):e42964, 04 Aug 2023
Cited by: 0 articles | PMID: 37667704 | PMCID: PMC10475319
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Role of Activating Transcription Factor 3 in Metformin's Alleviation of Gastrointestinal Injury Induced by Restraint Stress in Mice.
Siwakoti B, Lien TS, Lin YY, Pethaperumal S, Hung SC, Sun DS, Cheng CF, Chang HH
Int J Mol Sci, 24(13):10995, 01 Jul 2023
Cited by: 4 articles | PMID: 37446172 | PMCID: PMC10342009
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Metformin: update on mechanisms of action and repurposing potential.
Foretz M, Guigas B, Viollet B
Nat Rev Endocrinol, 19(8):460-476, 02 May 2023
Cited by: 105 articles | PMID: 37130947 | PMCID: PMC10153049
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin.
Abouelkheir M, Taher I, Eladl ASR, Shabaan DA, Soliman MFM, Taha AE
Pharmaceuticals (Basel), 16(5):658, 27 Apr 2023
Cited by: 0 articles | PMID: 37242441 | PMCID: PMC10222308
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Effect of metformin on sepsis-associated acute lung injury and gut microbiota in aged rats with sepsis.
Wan Y, Wang S, Niu Y, Duo B, Liu Y, Lu Z, Zhu R
Front Cell Infect Microbiol, 13:1139436, 09 Mar 2023
Cited by: 3 articles | PMID: 36968119 | PMCID: PMC10034768
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The optimization of sequential fermentation in the dealcoholized apple juice for reducing lipids.
Li H, Gao F, Wang Z, Gao Z
J Food Sci Technol, 60(7):2063-2077, 28 Apr 2023
Cited by: 0 articles | PMID: 37206421
Add to export list
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS^-/- mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Lavin B, Eykyn TR, Phinikaridou A, Xavier A, Kumar S, Buqué X, Aspichueta P, Sing-Long C, Arrese M, Botnar RM, Andia ME
NMR Biomed, 36(8):e4932, 11 Apr 2023
Cited by: 2 articles | PMID: 36940044 | PMCID: PMC10704844
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.
Zhang Y, Zhu X, Yu X, Novák P, Gui Q, Yin K
Front Nutr, 10:1120168, 02 Mar 2023
Cited by: 13 articles | PMID: 36937361 | PMCID: PMC10018175
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD).
Rong L, Zou J, Ran W, Qi X, Chen Y, Cui H, Guo J
Front Endocrinol (Lausanne), 13:1087260, 16 Jan 2023
Cited by: 46 articles | PMID: 36726464 | PMCID: PMC9884828
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC

1-25 of 58 results

1 2 3

Search life-sciences literature (45,103,589 articles, preprints and more)

Search results

Oral supplementation of choline attenuates the development of alcohol-related liver disease (ALD).

Advances in the mechanism of metformin with wide-ranging effects on regulation of the intestinal microbiota.

Advancements in metabolic-associated steatotic liver disease research: Diagnostics, small molecule developments, and future directions.

Oral Supplementation of Phosphatidylcholine Attenuates the Onset of a Diet-Induced Metabolic Dysfunction-Associated Steatohepatitis in Female C57BL/6J Mice.

Metformin: update on mechanisms of action on liver diseases.

Supplementing L-Citrulline Can Extend Lifespan in C. elegans and Attenuate the Development of Aging-Related Impairments of Glucose Tolerance and Intestinal Barrier in Mice.

The Role and Mechanism of Metformin in Inflammatory Diseases.

The role of anti-diabetic drugs in NAFLD. Have we found the Holy Grail? A narrative review.

The Effects of Probiotic Bacillus Spores on Dexamethasone-Treated Rats.

Non-alcoholic fatty liver disease: Immunological mechanisms and current treatments.

Fructose: a modulator of intestinal barrier function and hepatic health?

Comparing the Influences of Metformin and Berberine on the Intestinal Microbiota of Rats With Nonalcoholic Steatohepatitis.

TNFα is a key trigger of inflammation in diet-induced non-obese MASLD in mice.

The benefit of metformin in the treatment of pediatric non-alcoholic fatty liver disease: a systematic review and meta-analysis of randomized controlled trials.

Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice.

Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats.

The Influence of Insulin Resistance on Outcomes in Hospitalizations for Alcohol-Related Liver Disease: A Nationwide Study.

The Role of Activating Transcription Factor 3 in Metformin's Alleviation of Gastrointestinal Injury Induced by Restraint Stress in Mice.

Metformin: update on mechanisms of action and repurposing potential.

Detection and Quantification of Some Ethanol-Producing Bacterial Strains in the Gut of Mouse Model of Non-Alcoholic Fatty Liver Disease: Role of Metformin.

Effect of metformin on sepsis-associated acute lung injury and gut microbiota in aged rats with sepsis.

The optimization of sequential fermentation in the dealcoholized apple juice for reducing lipids.

Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS^-/- mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy.

Advancements in the treatment of non-alcoholic fatty liver disease (NAFLD).

Partnerships & funding